Detection of the BRAF mutation has shown promise in diagnosis of UC and prostate cancer in dogs7 although sensitivity can be as low as 64%8, and it is possible that miRNA biomarkers, especially from EVs, could represent complementary detection methods for UC. This evidence concerns the gene BRAF and prostate cancer.